Aehr Test Systems (AEHR) stock
Close on Nov 13, 2026Market cap $1.86BP/E –Yield –
Earnings
Aehr Test Systems's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Aehr Test Systems's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q2 FY2027ended Nov 28, 2026 | Jan 7, 2027Expected | – | – | – | – | – |
| Q1 FY2027ended Sep 25, 2026 | Nov 2, 2026after the close | $33.00M | +200.0% | $0.21 | $0.28 | Release |
| Q4 FY2026ended May 29, 2026 | Jul 14, 2026after the close | $18.80M | +33.3% | $0.04 | $0.11 | Release |
| Q3 FY2026ended Feb 27, 2026 | Apr 7, 2026after the close | $10.30M | -43.7% | -$0.10 | -$0.05 | Release |
| Q2 FY2026ended Nov 28, 2025 | Jan 8, 2026after the close | $9.90M | -26.7% | -$0.11 | -$0.04 | Release |
| Q1 FY2026ended Aug 29, 2025 | Oct 6, 2025after the close | $11.00M | -16.0% | -$0.07 | $0.01 | Release |
| Q4 FY2025ended May 30, 2025 | Jul 8, 2025after the close | $14.10M | -15.1% | -$0.10 | -$0.01 | Release |
| Q3 FY2025ended Feb 28, 2025 | Apr 8, 2025after the close | $18.30M | +140.8% | -$0.02 | $0.07 | Release |
| Q2 FY2025ended Nov 29, 2024 | Jan 13, 2025after the close | $13.50M | -36.9% | -$0.03 | $0.02 | Release |
| Q1 FY2025ended Aug 30, 2024 | Oct 10, 2024after the close | $13.10M | -36.4% | $0.02 | $0.07 | Release |
| Q4 FY2024ended May 31, 2024 | Jul 9, 2024after the close | $16.60M | -25.6% | – | – | Release |
| Q3 FY2024ended Feb 29, 2024 | Apr 9, 2024after the close | $7.60M | -55.8% | -$0.05 | -$0.03 | Release |
| Q2 FY2024ended Nov 30, 2023 | Jan 9, 2024after the close | $21.40M | +44.6% | $0.20 | $0.23 | Release |
| Q1 FY2024ended Aug 31, 2023 | Oct 5, 2023after the close | $20.60M | +92.5% | $0.16 | $0.18 | Release |
| Q4 FY2023ended May 31, 2023 | Jul 13, 2023after the close | $22.30M | – | $0.21 | $0.23 | Release |
| Q3 FY2023ended Feb 28, 2023 | Mar 30, 2023after the close | $17.20M | +12.4% | $0.14 | $0.16 | Release |
| Q2 FY2023ended Nov 30, 2022 | Jan 5, 2023after the close | $14.80M | +54.2% | $0.13 | $0.16 | Release |
| Q1 FY2023ended Aug 31, 2022 | Oct 6, 2022after the close | $10.70M | – | $0.02 | $0.05 | Release |
| Q3 FY2022ended Feb 28, 2022 | Mar 31, 2022after the close | $15.30M | – | $0.08 | $0.14 | Release |
| Q2 FY2022ended Nov 30, 2021 | Jan 6, 2022after the close | $9.60M | – | $0.03 | $0.05 | Release |
| Q4 FY2021ended May 31, 2021 | Jul 15, 2021after the close | – | – | – | – | Filing |
| Q3 FY2021ended Feb 28, 2021 | Apr 8, 2021after the close | – | – | – | – | Filing |
| Q2 FY2021ended Nov 30, 2020 | Jan 7, 2021after the close | – | – | – | – | Filing |
| Q1 FY2021ended Aug 31, 2020 | Sep 24, 2020after the close | – | – | – | – | Filing |
| Q4 FY2020ended May 31, 2020 | Jul 16, 2020after the close | – | – | – | – | Filing |
| Q3 FY2020ended Feb 29, 2020 | Apr 2, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Aehr Test Systems's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Revenue | FY2027 | $150.00M | – | New | Nov 2, 2026 |
| total company revenue | FY2027 | $130.00M – $150.00M | – | New | Jul 14, 2026 |
| non-GAAP net incomenon-GAAP | FY2027 | 18% – 22% | – | New | Jul 14, 2026 |
| Non-GAAP net incomenon-GAAP | FY2027 | 20% | – | New | Nov 2, 2026 |
Guidance vs results
The last range Aehr Test Systems gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2026 | Revenue | $45.00M – $50.00M | $50.00MΣ4Q | Within range |
Guidance history
Every forecast Aehr Test Systems put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 2, 2026 | Non-GAAP net income | FY2027 | 20% | New |
| Nov 2, 2026 | Revenue | FY2027 | $150.00M | New |
| Jul 14, 2026 | non-GAAP net income | FY2027 | 18% – 22% | New |
| Jul 14, 2026 | total company revenue | FY2027 | $130.00M – $150.00M | New |
| Apr 7, 2026 | non-GAAP net loss per diluted share | FY2026 | -$0.09 – -$0.05 | Reaffirmed |
| Apr 7, 2026 | bookings | FY2026 | $60.00M – $80.00M | New |
| Apr 7, 2026 | revenue | FY2026 | $45.00M – $50.00M | New |
| Apr 7, 2026 | revenue | FY2026 | $25.00M – $30.00M | Reaffirmed |
| Jan 8, 2026 | non-GAAP net loss per diluted share | FY2026 | -$0.09 – -$0.05 | New |
| Jan 8, 2026 | revenue | FY2026 | $25.00M – $30.00M | New |
| Jan 13, 2025 | non-GAAP net profit before taxes | FY2025 | 10% | New |
| Jan 13, 2025 | total revenue | FY2025 | $70.00M | Reaffirmed |
| Oct 10, 2024 | net profit before taxes | FY2025 | 10% | New |
| Oct 10, 2024 | total revenue | FY2025 | $70.00M | New |
| Apr 9, 2024 | per diluted share | FY2024 | $0.38 | New |
| Apr 9, 2024 | GAAP net income | FY2024 | $11.00M | Lowered |
| Apr 9, 2024 | total revenue | FY2024 | $65.00M | Lowered |
| Jan 9, 2024 | GAAP net income | FY2024 | 20% – 25% | New |
| Jan 9, 2024 | total revenue | FY2024 | $75.00M – $85.00M | Lowered |
| Oct 5, 2023 | GAAP net income | FY2024 | $28.00M | Reaffirmed |
| Oct 5, 2023 | total revenue | FY2024 | $100.00M | Reaffirmed |
| Jul 13, 2023 | GAAP net income | FY2024 | $28.00M | New |
| Jul 13, 2023 | total revenue | FY2024 | $100.00M | New |
| Mar 30, 2023 | total revenue | FY2023 | $60.00M – $70.00M | Reaffirmed |
| Jan 5, 2023 | total revenue | FY2023 | $60.00M – $70.00M | Reaffirmed |
| Oct 6, 2022 | total revenue | FY2023 | $60.00M – $70.00M | New |
| Mar 31, 2022 | total revenue | FY2022 | $50.00M | Reaffirmed |
| Jan 6, 2022 | total revenue | FY2022 | $50.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Aehr Test Systems filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Update
- Results
- Results
See a number that looks wrong?